Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic management of epithelial ovarian cancer during pregnancy

  • Educational Series – Red Series
  • NEW TRENDS IN CLINICAL ONCOLOGY
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Epithelial ovarian cancer (EOC) during pregnancy is a rare condition. The diagnosis and treatment strategies are therefore not well defined. The evidence is scarce and limited to small case reports or case series. In this review we describe the safety, utility and limitations of each diagnostic tool and surgical procedure in pregnant women with ovarian cancer. We also discuss the role of chemotherapy for ovarian cancer during pregnancy. Finally, we delineate different strategies of treatment according to the stage of the disease at diagnosis and gestational age. Due to the complexity of the management of EOC during pregnancy, patients should be referred to specialized centers. Gestational age at diagnosis, the initial surgical procedure, disease stage and patient’s preferences are the key factors in the decision-making process to establish the best treatment strategy for each individual case.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Morice P, Uzan C, Gouy S, Verschraegen C, Haie-Meder C (2012) Gynaecological cancer in pregnancy. Lancet 379:558–569

    Article  PubMed  Google Scholar 

  2. Malfetano JH, Goldkrand JW (1990) Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol 75:545–547

    PubMed  CAS  Google Scholar 

  3. Creasman WT, Rutledge F, Smith JP (1971) Carcinoma of the ovary associated with pregnancy. Obstet Gynecol 38:111–116

    PubMed  CAS  Google Scholar 

  4. Copeland LJ, London MB (1996) Malignant disease in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL (eds) Obstetrics, normal, and problem pregnancies, 3rd edn. Churchill Livingstone, New York, pp 1155–1181

    Google Scholar 

  5. Palmer J, Vatish M, Tidy J (2009) Epithelial ovarian cancer in pregnancy: a review of the literature. BJOG 116:480–491

    Article  PubMed  CAS  Google Scholar 

  6. Kobayashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T (1989) Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol 160:563–566

    PubMed  CAS  Google Scholar 

  7. Halila H, Stenman U, Seppalla M (1986) Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer 57:1327–1329

    Article  PubMed  CAS  Google Scholar 

  8. American College of Obstetricians and Gynecologists. ACOG committee Opinion No 299 (2004) Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 104:647–651

    Article  Google Scholar 

  9. Amant F, Van Calsteren K, Halaska MJ, Beijnen J, Lagae L, Hanssens M et al (2009) Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer 19(Suppl 1):S1–S12

    Article  PubMed  Google Scholar 

  10. Brenner DJ, Hall EJ (2007) Computed tomography an increasing source of radiation exposure. N Engl J Med 357:2277–2284

    Article  PubMed  CAS  Google Scholar 

  11. Zanotti-Fregonara P, Jan S, Taieb D et al (2010) Absorbed 18F-FDG dose to the fetus during early pregnancy. J Nucl Med 51:803–805

    Article  PubMed  Google Scholar 

  12. Zanotti-Fregonara P, Champion C, Trébossen R, Maroy R, Devaux JY, Hindié E (2008) Stimulation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med 49:679–682

    Article  PubMed  Google Scholar 

  13. Reedy MB, Källén B, Kuehl TJ (1997) Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedish Health Registry. Am J Obstet Gynecol 177:673–679

    Article  PubMed  CAS  Google Scholar 

  14. Akira S, Yamanaka A, Ishihara T, Takeshita T, Araki T (1999) Gasless laparoscopic ovarian cystectomy during pregnancy: comparison with laparotomy. Am J Obstet Gynecol 180:554–557

    Article  PubMed  CAS  Google Scholar 

  15. Friedman JD, Ramsey PS, Ramin KD et al (2002) Pneumoamnion and pregnancy loss after second-trimester laparoscopic surgery. Obstet Gynecol 299:512–513

    Article  Google Scholar 

  16. Sayedur Rahman M, Al-Sibai MH, Rahman J, Al-Suleiman SA, El-Yahia AR, Al-Mulhim AA et al (2002) Ovarian carcinoma associated with pregnancy. A review of 9 cases. Acta Obstet Gynecol Scand 81:260–264

    Article  PubMed  Google Scholar 

  17. Ferrandina G, Distefano M, Testa A, De Vincenzo R, Scambia G (2005) Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review. Gynecol Oncol 97:693–696

    Article  PubMed  Google Scholar 

  18. Stuart GC, Kitchener H, Bacon M, duBois A, Friedlander M, Ledermann J, Marth C, Thigpen T, Trimble E, Participants of 4th Ovarian Cancer Consensus Conference (OCCC), Gynecologic Cancer Intergroup (2011) 2010 gynecologic cancer intergroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the fourth ovarian cancer consensus conference. Int J Gynecol Cancer 21(4):750–755

    Google Scholar 

  19. Mercer BM (2003) Preterm premature rupture of the membranes. Obstet Gynecol 101:178–193

    Article  PubMed  Google Scholar 

  20. NIH (2000) Antenatal corticosteroids revisited: repeat courses. NIH consensus statement 2000 August 17–18. Am J Obstet Gynecol 17(2):1–18

    Google Scholar 

  21. Teratology Society Public Affairs Committee (1994) FDA classification of drugs for teratogenic risk. Teratology 49:446–447

    Article  Google Scholar 

  22. Brewer M, Kueck A, Runowicz C (2011) Chemotherapy in pregnancy. Clin Obstet Gynecol 54(4):602–618

    Article  PubMed  Google Scholar 

  23. Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5:283–291

    Article  PubMed  CAS  Google Scholar 

  24. Ebert U, Loffler H, Kirch W (1997) Cytotoxic therapy and pregnancy. Pharmacol Ther 74:207–220

    PubMed  CAS  Google Scholar 

  25. Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683–689

    Article  PubMed  Google Scholar 

  26. Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser F (2008) Use of platinum derivatives during pregnancy. Cancer 113:3069–3074

    Article  PubMed  CAS  Google Scholar 

  27. Li RH, Tam WH, Ng PC, Mok TS, Tam B, Lau TK (2007) Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report. J Reprod Med 52:575–576

    PubMed  Google Scholar 

  28. Henderson C, Elia G, Garfinkel D, Poirier MC, Shamkhani H, Runowicz CD (1993) Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol 49:92–94

    Article  PubMed  CAS  Google Scholar 

  29. Koc O, McFee M, Reed E, Gerson SL (1994) Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure. Eur J Cancer 30:716–717

    Article  Google Scholar 

  30. Picone O, Lhommé C, Tournaire M, Pautier P, Camatte S, Vacher-Lavenue MC et al (2004) Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol 94:600–604

    Article  PubMed  Google Scholar 

  31. Tabata T, Nishiura K, Tanida K, Kondo E, Okugawa T, Sagawa N (2008) Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. Int J Gynecol Cancer 18:181–184

    Article  PubMed  CAS  Google Scholar 

  32. Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F et al (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 21:425–426

    Article  PubMed  CAS  Google Scholar 

  33. Cardonick E, Usmani A, Ghaffar S (2010) Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 33:221–228

    PubMed  CAS  Google Scholar 

  34. FIGO, Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U (2006) Carcinoma of the ovary. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95:S161–S192

    Article  PubMed  Google Scholar 

  35. Tropé C, Kaern J (2007) Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J Clin Oncol 25:2909–2920

    Article  PubMed  Google Scholar 

  36. American College of Obstetricians and Gynecologists (2007) ACOG practice bulletin: management of adnexal masses. Obstet Gynecol 110:201–214

    Article  Google Scholar 

  37. Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S et al (2010) Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 28:1727–1732

    Article  PubMed  Google Scholar 

  38. Colombo N, Guthrie D, Chiari S, Parmar M, Qian W, Swart AM, International collaborative ovarian neoplasm (ICON) collaborators et al (2003) International collaborative ovarian neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 95:125–132

    Article  PubMed  Google Scholar 

  39. Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, International Collaborative Ovarian Neoplasm 1, European Organisation for Research and Treatment of Cancer Collaborators–Adjuvant Chemotherapy in Ovarian Neoplasm et al (2003) Impact of adjuvant chemotherapy and surgical staging in early stage ovarian carcinoma: European organisation for research and treatment of cancer–adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst 95:113–125

    Article  PubMed  CAS  Google Scholar 

  40. Marret H, Lhommé C, Lecuru F, Canis M, Lévèque J, Golfier F et al (2010) Guidelines for the management of ovarian cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 149:18–21

    Article  PubMed  Google Scholar 

  41. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248–1259

    Article  PubMed  Google Scholar 

  42. Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N et al, European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group, NCIC Clinical Trials Group (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943–953

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Gynecology Oncology Program, Hospital Universitario Madrid Sanchinarro, Centro Integral Oncológico Clara Campal (CIOCC), Calle Oña 10, 28050, Madrid, Spain

    L. Minig, I. Diaz-Padilla, R. Alvarez Gallego, M. G. Patrono & J. Valero de Bernabé

  2. Division of Obstetrics, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    L. Otaño

Authors
  1. L. Minig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Otaño
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Diaz-Padilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Alvarez Gallego
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. G. Patrono
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Valero de Bernabé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. G. Patrono.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minig, L., Otaño, L., Diaz-Padilla, I. et al. Therapeutic management of epithelial ovarian cancer during pregnancy. Clin Transl Oncol 15, 259–264 (2013). https://doi.org/10.1007/s12094-012-0963-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-012-0963-3

Keywords

Search

Navigation